logo

RDY

Dr. Reddy'S Laboratories·NYSE
--
--(--)
--
--(--)

RDY fundamentals

Dr. Reddy'S Laboratories (RDY) released its earnings on Jan 21, 2026: revenue was 951.64M (YoY -1.85%), beat estimates; EPS was 0.1583 (YoY -19.44%), missed estimates.
Revenue / YoY
951.64M
-1.85%
EPS / YoY
0.1583
-19.44%
Report date
Jan 21, 2026
RDY Earnings Call Summary for Q3,2026
  • Revenue Beat Expectations: 4.4% YoY growth driven by double-digit base business growth and India's 19% YoY expansion.
  • Semaglutide Momentum: India launch in March 2026, Canada approval by May 2026, with global capacity of 12 million cartridges.
  • Biosimilar Pipeline Progress: Abatacept IV BLA filed, denosumab partner addressing CRL, and rituximab inspection ongoing.
  • Sustainability Commitment: Science-based net-zero target by 2045, recognized for climate leadership.
  • Margin Challenges: 500+ bps gross margin decline due to Lenalidomide decline, offset by 25%+ EBITDA margin in NRT business.
EPS
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Q4,2025
Q1,2026
Q2,2026
Q3,2026
Actual
0.12140.09320.12410.00330.09090.09230.15930.11320.12980.1790.16220.18370.14040.20560.21330.1990.18760.19930.17840.19650.22380.1970.19640.1583
Forecast
0.08750.08450.09890.1160.10250.10930.11240.12740.10190.10220.11290.1360.11510.1540.17460.17660.17640.19230.20640.2090.21150.21440.19270.1622
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+38.74%
+10.30%
+25.48%
-97.16%
-11.32%
-15.55%
+41.73%
-11.15%
+27.38%
+75.15%
+43.67%
+35.07%
+21.98%
+33.51%
+22.16%
+12.68%
+6.35%
+3.64%
-13.57%
-5.98%
+5.82%
-8.12%
+1.92%
-2.40%
Revenue
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Q4,2025
Q1,2026
Q2,2026
Q3,2026
Actual
--------------------584.65M590.57M662.82M675.66M645.77M661.38M769.74M708.93M699.44M653.93M764.59M829.77M767.05M822.36M826.44M868.04M848.07M916.27M951.11M969.62M996.16M988.91M1.00B951.64M
Forecast
--------------------561.48M556.17M640.91M681.07M656.19M677.83M696.64M732.85M678.75M679.18M695.50M729.14M745.17M777.84M816.23M833.41M847.64M875.74M918.01M950.54M978.20M1.01B979.76M943.77M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+4.13%
+6.19%
+3.42%
-0.79%
-1.59%
-2.43%
+10.49%
-3.26%
+3.05%
-3.72%
+9.93%
+13.80%
+2.94%
+5.72%
+1.25%
+4.15%
+0.05%
+4.63%
+3.61%
+2.01%
+1.84%
-2.56%
+2.30%
+0.83%

Earnings Call